Christopher Clinton Conway: I am thrilled to present the first annual, Dr. Susan Love Visionary Award, to Andy DeLaO, on May 7, 2024
Christopher Clinton Conway, Chief Executive Officer and Member of the Board of Directors at
“I am thrilled to present the first annual, Dr. Susan Love Visionary Award, to Andy DeLaO, on May 7, 2024, at the Beverly Wilshire!
Andy’s dedication to patient centered care is demonstrated in his ability to combine design with people, process, and technology to provide patients the power to choose the speed in which they receive care, going from diagnosis to treatment options in 72 hours or less.
In support of Dr. Love’s research, Andy and his colleagues at GE Health Care made a groundbreaking study, sponsored by The National Institutes of Health, possible through a major donation of hardware and the development of leading-edge software. The result is a momentous advance for the treatment of patients in low resource environments, everywhere in the world, by demonstrating that AI enabled imaging can be obtained with a handheld device by minimally trained clinical staff. An enormous expansion for the reach of screenings across rural and undeveloped communities in the U.S. and abroad.
Andy is the Chief Strategy and Marketing Officer for GE HealthCare’s business focused on building care at the n-of-1 using the diagnostic gateway to precision health and care. He has a clinical background in radiation oncology and physics. He has led teams to design and run 25 cancer centers and 150 risk reduction facilities globally. He sits on the Board of Directors for Avant Diagnostics, Inc., and American College of Radiology’s Patient and Family Centered Care Committee.
Please plan to join the celebration! For tickets and tables, visit our website.”